Somatostatin and growth hormone regulation in cancer

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Somatostatin analogues are used clinically in a variety of pituitary and gastroenteropancreatic tumours. In addition, they may influence breast and prostate growth either directly through somatostatin receptors or indirectly through inhibition of growth hormone and prolactin release. Somatostatin analogues may interfere with EGF/TGF α-stimulated growth of these tumours and can suppress circulating levels of IGF-I in addition.

Original languageEnglish (US)
Pages (from-to)31-36
Number of pages6
Issue number1
StatePublished - Jan 1992

All Science Journal Classification (ASJC) codes

  • Pharmacology


Dive into the research topics of 'Somatostatin and growth hormone regulation in cancer'. Together they form a unique fingerprint.

Cite this